L14- Asthma and COPD Flashcards
What is asthma?
Recurrent reversible obstruction of the airways in response to a stimuli that are not themselves noxious and which do not affect non-asthmatic subjects
What are the main characteristics of asthma?
- Airway obstruction
- Airway inflammation
- Increased bronchial hyperresponsiveness to a wide variety of stimuli
What does a diseased lung look like?
- Bifurcations not visible
- Inflamed walls of airways
- Mucus filled conducting airways
- Oedema and vascular leakage
What is a house dust mite?
- Microorganism found everywhere
- Eats skin scales and uses enzymes to metabolise which are released in inhalable faeces
- Some people are genetically predisposed to produce IgE antibodies towards faeces of HDM and cause allergic response
How does hyperresponsiveness occur?
- Epithelium constantly disrupted due to allergen response
* Damaged epithelium exposes sensory nerves which respond to temperature, humidity and irritants in the air
What are the short-acting b agonists?
- Salbutamol
- Levalbuterol
- Terbutaline
What are the short acting anti muscarinics?
- Ipratropium
* Oxitropium
What are the long-acting b agonists?
- Salmeterol
* Indacaterol
What are the long acting anti muscarinics?
- Tiotropium
* Aclidinium
What are methylxanthines?
- Theophylline
* Doxophylline
What are fixed combination LABA/LAMA drugs?
- Salbutamol and ipratropium
- Indacaterol and glycopyrronium
- Vilanterol and umeclidinium
What are fixed combination LABA/ICS?
- Formoterol and budesonide
* Salmeterol and fluticasone
What do b agonists do?
- Mimic sympathetic nervous system activity and induce bronchiole smooth muscle relaxation (bronchodilation)
- No effect on inflammation
- Immediate relief in asthma attack
What do muscarinic antagonists do?
- Block parasympathetic induced bronchiole smooth muscle contraction by blocking Ach muscarinic receptors
- No effect on inflammation
How are LABA/LAMA combinations useful?
- Further enhances bronchodilation by amplifying the effects of one another
- Can help overcome intra and inter patient variability